0.7259
Inspira Technologies Oxy B H N Ltd Borsa (IINN) Ultime notizie
IINN’s Financial Health: Exploring Inspira Technologies Oxy B.H.N. Ltd’s Debt-to-Equity Ratio of 1.79 - investchronicle.com
Inspira Technologies’ ART100 Gains Traction in U.S. Hospitals - TipRanks
Inspira Technologies (IINN) Sees Boost in Commercial Interest Due to ART100 System | IINN Stock News - GuruFocus
Inspira Technologies Begins Commercial Adoption of FDA-Cleared ART100 System, Driving Global Interest in Life-Support Innovations - Nasdaq
Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions - The Manila Times
Inspira's ART100 Life Support System Deployed at Top US Hospitals | IINN Stock News - Stock Titan
Citadel Advisors LLC Has $88,000 Stake in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) - Defense World
Inspira Technologies boosts production of FDA-cleared system By Investing.com - Investing.com South Africa
CORRECTIONInspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority - The Manila Times
Inspira Technologies (IINN) Boosts Production for Anticipated Eu - GuruFocus
Inspira Technologies boosts production of FDA-cleared system - Investing.com
Inspira Technologies Boosts ART100 Production Amid European Negotiations - TipRanks
Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority - The Manila Times
Inspira Technologies Scales Up Production of INSPIRA ART100 System Amid European Procurement Negotiations - Nasdaq
Research Analysts Offer Predictions for IINN FY2025 Earnings - Defense World
Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) Raised to Strong-Buy at Litchfield Hills Research - Defense World
Litchfield Hills Initiates Coverage of Inspira Technologies Oxy B.H.N. (IINN) with Buy Recommendation - Nasdaq
Inspira Technologies Oxy (IINN) Coverage Initiated with 'Buy' Rating | IINN Stock News - GuruFocus
Inspira Technologies (IINN) Receives Buy Rating from Analyst | I - GuruFocus
Inspira Technologies Receives $2 Price Target And Buy Rating: Everything You Need To Know - MENAFN.com
Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) Trading Up 9.3% – Still a Buy? - Defense World
Inspira Technologies Announces Shareholder Meeting to Address Nasdaq Compliance - TipRanks
Inspira Technologies ramps up ART100 system commercialization By Investing.com - Investing.com South Africa
Inspira (IINN) Strategizes for Enhanced U.S. Commercialization o - GuruFocus
Inspira Technologies Begins Rollout of ART100 System; Shares Rise - marketscreener.com
Inspira Technologies Initiates Global Commercial Rollout of FDA -Cleared ART100 System - marketscreener.com
Inspira Technologies ramps up ART100 system commercialization - Investing.com Australia
Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System - The Manila Times
Inspira Technologies Announces Strategic Shift to Accelerate Commercialization of INSPIRA ART100 System - Nasdaq
Inspira's FDA-Cleared Alternative to Mechanical Ventilation Begins Worldwide Launch After US Success - Stock Titan
Inspira Technologies Restructures Executive Team for Strategic Alignment - TipRanks
Inspira Technologies restructures executive team By Investing.com - Investing.com South Africa
Inspira Technologies (IINN) Restructures Leadership for Strategi - GuruFocus
Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives - The Manila Times
Inspira Technologies restructures executive team - Investing.com
Inspira Technologies Co-Founder Exits President Role as Company Pivots Strategy - Stock Titan
Inspira Technologies stock hits 52-week low at $0.46 By Investing.com - Investing.com South Africa
Inspira Technologies stock hits 52-week low at $0.46 - Investing.com
Inspira Technologies Shareholders Approve Key Agenda Items at May 2025 Meeting - TipRanks
Renaissance Technologies LLC Boosts Stock Position in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) - Defense World
Inspira’s ART100 system set for transplant validation in Israel By Investing.com - Investing.com South Africa
Stock Performance Spotlight: Inspira Technologies Oxy B.H.N. Ltd (IINN) Ends the Day at 0.58, Down by -3.78 - DWinneX
Inspira’s ART100 System Gains Approval for Organ Transplant Use in Israel - TipRanks
Inspira’s ART100 system set for transplant validation in Israel - Investing.com
INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients - The Manila Times
Inspira Technologies' INSPIRA ART100 Approved for Clinical Validation in Organ Transplant Procedures by Israel's Largest Healthcare Provider - Nasdaq
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):